Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia
Clinical trial NCT02899455 · COMPLETED
Trial details
- NCT number
- NCT02899455
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-06-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.